Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open,Single-center,Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

NCT06302062 is registered in ClinicalTrials.gov with Guangzhou FineImmune Biotechnology Co., LTD. as lead sponsor.

NCT NCT06302062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open,Single-center,Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Lead sponsor
Guangzhou FineImmune Biotechnology Co., LTD.
Phase
Phase 1
Overall status
Recruiting
Start date
June 6, 2023
Completion date
June 30, 2026
Enrollment
23 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, immunotherapy, tumor associated lymph node t cell